192 related articles for article (PubMed ID: 32586581)
1. Treatment of Histologic Transformation.
Casulo C
Hematol Oncol Clin North Am; 2020 Aug; 34(4):785-794. PubMed ID: 32586581
[TBL] [Abstract][Full Text] [Related]
2. Transformed follicular lymphoma.
Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
[TBL] [Abstract][Full Text] [Related]
3. Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.
Wong E; Dickinson M
Curr Oncol Rep; 2012 Oct; 14(5):424-32. PubMed ID: 22865028
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of follicular lymphoma: A comprehensive review.
Dada R
Eur J Haematol; 2019 Sep; 103(3):152-163. PubMed ID: 31270855
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Biological Prognostic Factors in Follicular Lymphoma.
Patel AA; Smith SM
Hematol Oncol Clin North Am; 2020 Aug; 34(4):647-662. PubMed ID: 32586571
[TBL] [Abstract][Full Text] [Related]
6. Transformed follicular non-Hodgkin lymphoma.
Casulo C; Burack WR; Friedberg JW
Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
[TBL] [Abstract][Full Text] [Related]
7. Transformation of follicular lymphoma.
Lossos IS; Gascoyne RD
Best Pract Res Clin Haematol; 2011 Jun; 24(2):147-63. PubMed ID: 21658615
[TBL] [Abstract][Full Text] [Related]
8. Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma.
Lerner RE; Burns LJ
Bone Marrow Transplant; 2003 Apr; 31(7):531-7. PubMed ID: 12692617
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with transformed lymphoma.
Montoto S
Hematology Am Soc Hematol Educ Program; 2015; 2015():625-30. PubMed ID: 26637780
[TBL] [Abstract][Full Text] [Related]
10. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Hamouzova M; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
Ann Hematol; 2018 Apr; 97(4):669-678. PubMed ID: 29318369
[TBL] [Abstract][Full Text] [Related]
11. Transformed lymphoma: what should I do now?
Smith S
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):306-311. PubMed ID: 33275671
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).
Wagner-Johnston ND; Link BK; Byrtek M; Dawson KL; Hainsworth J; Flowers CR; Friedberg JW; Bartlett NL
Blood; 2015 Aug; 126(7):851-7. PubMed ID: 26105149
[TBL] [Abstract][Full Text] [Related]
13. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
[TBL] [Abstract][Full Text] [Related]
14. Follicular lymphoma grade 3: review and updates.
Vaidyanathan G; Czuczman MS
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
[TBL] [Abstract][Full Text] [Related]
15. Novel acquisitions on biology and management of transformed follicular lymphoma.
Minoia C; Zucca E; Conconi A
Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
[TBL] [Abstract][Full Text] [Related]
16. The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
Br J Haematol; 2016 Oct; 175(1):102-14. PubMed ID: 27341313
[TBL] [Abstract][Full Text] [Related]
17. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
[TBL] [Abstract][Full Text] [Related]
18. Predicting transformation in follicular lymphoma.
de Jong D; de Boer JP
Leuk Lymphoma; 2009 Sep; 50(9):1406-11. PubMed ID: 19606378
[TBL] [Abstract][Full Text] [Related]
19. Histologic transformation in follicular lymphoma.
Salles G; Coiffier B
Ann Oncol; 1998 Aug; 9(8):803-5. PubMed ID: 9789600
[No Abstract] [Full Text] [Related]
20. Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
Alonso-Álvarez S; Manni M; Montoto S; Sarkozy C; Morschhauser F; Wondergem MJ; Guarini A; Magnano L; Alcoceba M; Chamuleau M; Galimberti S; Gomes da Silva M; Holte H; Zucca E; Lockmer S; Aurer I; Marcheselli L; Stepanishyna Y; Caballero Barrigón MD; Salles G; Federico M
Eur J Cancer; 2021 Nov; 157():132-139. PubMed ID: 34508995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
